Cero Therapeutics Holdings, Inc. - Initial Ownership Filing
Ticker: CERO · Form: 3 · Filed: Apr 21, 2026 · CIK: 0001870404
Sentiment: neutral
Topics: insider-filing, ownership
TL;DR
Cero Therapeutics Holdings, Inc. filed a Form 3 on 2026-02-13, showing initial beneficial ownership of securities.
AI Summary
On February 13, 2026, Francois Eric filed an initial statement of beneficial ownership of securities for Cero Therapeutics Holdings, Inc. The filing, designated as Form 3, indicates a change in ownership for the company's securities. The specific details of the ownership change and the number of shares involved are not provided in this summary document.
Why It Matters
This filing marks the initial reporting of beneficial ownership for securities in Cero Therapeutics Holdings, Inc., providing transparency for investors regarding who holds significant stakes in the company.
Risk Assessment
Risk Level: low — Form 3 filings are routine and report initial ownership, not necessarily indicating a change in company performance or risk.
Key Players & Entities
- Francois Eric (person) — Reporting Person
- CERO THERAPEUTICS HOLDINGS, INC. (company) — Issuer
- 0001870404 (company) — Issuer CIK
- 0001213900-26-046328 (filing_id) — SEC Accession Number
- 2026-04-21 (date) — Filing Date
- 2026-02-13 (date) — Period of Report
FAQ
What type of SEC filing is this?
This is a Form 3 - Initial statement of beneficial ownership of securities.
Who is the issuer in this filing?
The issuer is CERO THERAPEUTICS HOLDINGS, INC. (CIK: 0001870404).
When was the period of report for this filing?
The period of report was 2026-02-13.
What is the SEC accession number for this filing?
The SEC accession number is 0001213900-26-046328.
Who is the reporting person associated with this filing?
Francois Eric is listed as the reporting person.
Filing Details
This Initial Statement of Beneficial Ownership (Form 3) was filed with the SEC on April 21, 2026 by Francois Eric regarding CERO THERAPEUTICS HOLDINGS, INC. (CERO). Form 3 filings establish the initial ownership position of company insiders when they first assume their role.